Extrahepatic Cholangiocarcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who underwent clinical and imaging examinations, including ultrasound, CT, MRI, or other imaging modalities, within 2 weeks before surgery; 2. Patients with pathologically confirmed extrahepatic cholangiocarcinoma (ECC) based on hematoxylin and eosin (H&E) staining; 3. Patients aged 18–90 years.
Exclusion criteria
Exclusion criteria: 1. Patients with severe artifacts on imaging scans or poor-quality pathological images; 2. Patients with incomplete data; 3. Participants with concomitant primary tumors at other anatomical sites will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prediction of pathological status, molecular features, and prognostic risk in ECC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Interpretability and biological mechanism analysis of ECC prediction models;Segmentation, identification, and annotation of ECC lesions on multimodal images; | — |
Countries
China
Contacts
The Affiliated Hospital of Southwest Medical University